[HTML][HTML] A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma

M Sánchez-Ortega, A Garrido, C Cirauqui… - Redox biology, 2024 - Elsevier
Extensive efforts have been conducted in the search for new targetable drivers of lung
squamous cell carcinoma (LUSC); to date, however, candidates remain mostly …

Towards More Precise Targeting of Inhaled Aerosols to Different Areas of the Respiratory System

TR Sosnowski - Pharmaceutics, 2024 - mdpi.com
Pharmaceutical aerosols play a key role in the treatment of lung disorders, but also systemic
diseases, due to their ability to target specific areas of the respiratory system (RS). This …

High-flow nasal cannula and in-line aerosolised bronchodilator delivery during severe exacerbation of asthma in adults: a feasibility observational study

N Colaianni-Alfonso, A Toledo, G Montiel… - … Critical Care & Pain …, 2024 - Elsevier
Background Asthma is a common chronic respiratory disease affecting 1–29% of the
population in different countries. Exacerbations represent a change in symptoms and lung …

Performance Characterisation of the Airvo2TM Nebuliser Adapter in Combination with the Aerogen SoloTM Vibrating Mesh Nebuliser for in Line Aerosol Therapy …

R MacLoughlin, M Mac Giolla Eain - Pharmaceutics, 2024 - mdpi.com
High flow oxygen (HFO) therapy is a well-established treatment in respiratory disease.
Concurrent aerosol delivery can greatly expediate their recovery. The aim of this work was to …

[PDF][PDF] Performance Characterisation of the Airvo2 Nebuliser Adapter in Combination with the Aerogen Solo Vibrating Mesh Nebuliser for in Line Aerosol Therapy …

R MacLoughlin, M Mac Giolla Eain - 2024 - lenus.ie
High flow oxygen (HFO) therapy is a well-established treatment in respiratory disease.
Concurrent aerosol delivery can greatly expediate their recovery. The aim of this work was to …